Table 1.
Demographics and SARS-CoV-2 IgG/IgM status in multiple sclerosis (MS) patients, low-risk population, and high-risk population.
| MS Patients (n = 310) |
Low-Risk Population (n = 862) |
High-Risk Population (n = 235) |
|
|---|---|---|---|
| Age, years | 42.3 ± 12.4 | 42.9 ± 13.3 | 39.4 ± 10.9 |
| Sex, females (%) | 208 (67.1%) | 412 (47.8%) | 128 (54.5%) |
| SARS-CoV-2 status, number (prevalence %) | |||
| IgG or IgM positive | 9 (2.9%) | 11 (1.3%) | 25 (10.6%) |
| Females | 6 (2.9%) | 7 (1.7%) | 14 (10.9%) |
| Males | 3 (2.9%) | 4 (0.9%) | 11 (10.3%) |
| IgG positive | 9 (2.9%) | 5 (0.6%) | 9 (3.8%) |
| IgM positive | 0 (0%) | 6 (0.7%) | 8 (3.4%) |
| IgM and IgG positive | 0 (0%) | 0 (0%) | 8 (3.4%) |